CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
NCT02331693
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Advanced Glioma
Interventions
BIOLOGICAL:
anti-EGFR CAR T
Sponsor
RenJi Hospital